| UniProt ID | UBQL2_MOUSE | |
|---|---|---|
| UniProt AC | Q9QZM0 | |
| Protein Name | Ubiquilin-2 | |
| Gene Name | Ubqln2 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 638 | |
| Subcellular Localization | Cytoplasm . Nucleus . Membrane . Cytoplasmic vesicle, autophagosome . Colocalizes with a subset of proteasomes, namely those that are cytoskeleton associated or free in the cytosol. Associated with fibers in mitotic cells. | |
| Protein Description | Plays an important role in the regulation of different protein degradation mechanisms and pathways including ubiquitin-proteasome system (UPS), autophagy and the endoplasmic reticulum-associated protein degradation (ERAD) pathway. Mediates the proteasomal targeting of misfolded or accumulated proteins for degradation by binding (via UBA domain) to their polyubiquitin chains and by interacting (via ubiquitin-like domain) with the subunits of the proteasome. Plays a role in the ERAD pathway via its interaction with ER-localized proteins FAF2/UBXD8 and HERPUD1 and may form a link between the polyubiquitinated ERAD substrates and the proteasome. Involved in the regulation of macroautophagy and autophagosome formation; required for maturation of autophagy-related protein LC3 from the cytosolic form LC3-I to the membrane-bound form LC3-II and may assist in the maturation of autophagosomes to autolysosomes by mediating autophagosome-lysosome fusion. Negatively regulates the endocytosis of GPCR receptors: AVPR2 and ADRB2, by specifically reducing the rate at which receptor-arrestin complexes concentrate in clathrin-coated pits (CCPs) (By similarity). Links CD47 to vimentin-containing intermediate filaments of the cytoskeleton. [PubMed: 10549293] | |
| Protein Sequence | MAENGESSGPPRPSRGPAAAPGAASPPAEPKIIKVTVKTPKEKEEFAVPENSTVQQFKEAISKRFKSQTDQLVLIFAGKILKDQDTLMQHGIHDGLTVHLVIKSQNRPQGQATTQPSTTAGTSTTTTTTTTAAAPAATTSSAPRSSSTPTTTNSSSFGLGSLSSLSNLGLNSPNFTELQNQMQQQLLASPEMMIQIMENPFVQSMLSNPDLMRQLIMANPQMQQLIQRNPEISHLLNNPDIMRQTLEIARNPAMMQEMMRNQDLALSNLESIPGGYNALRRMYTDIQEPMLNAAQEQFGGNPFATVGSSSTSGEGTQPSRTENRDPLPNPWAPPPTTQTAATTTTTTTTSSGSGSGSSSSSTTAGNTMAAANYVASIFSTPGMQSLLQQITENPQLIQNMLSAPYMRSMMQSLSQNPDMAAQMMLSSPLFTSNPQLQEQMRPQLPNFLQQMQNPETIAAMSNPRAMQALMQIQQGLQTLATEAPGLIPSFAPGVGMGVLGTAITPVGPVTPIGPIGPIVPFTPIGPIGPIGPTGPASSPGSTGTGIPPATTVSSSAPTETISPTSESGPNQQFIQQMVQALTGGSPPQPPNPEVRFQQQLEQLNAMGFLNREANLQALIATGGDINAAIERLLGSQPS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAENGESSG ------CCCCCCCCC | 20.97 | - | |
| 8 | Phosphorylation | MAENGESSGPPRPSR CCCCCCCCCCCCCCC | 51.52 | 24719451 | |
| 14 | Phosphorylation | SSGPPRPSRGPAAAP CCCCCCCCCCCCCCC | 51.66 | 29514104 | |
| 25 | Phosphorylation | AAAPGAASPPAEPKI CCCCCCCCCCCCCCE | 30.77 | 25521595 | |
| 31 | Ubiquitination | ASPPAEPKIIKVTVK CCCCCCCCEEEEEEC | 48.87 | 22790023 | |
| 41 | Ubiquitination | KVTVKTPKEKEEFAV EEEECCCCHHHCCCC | 83.25 | 22790023 | |
| 43 | Acetylation | TVKTPKEKEEFAVPE EECCCCHHHCCCCCC | 69.53 | - | |
| 43 | Ubiquitination | TVKTPKEKEEFAVPE EECCCCHHHCCCCCC | 69.53 | 22790023 | |
| 58 | Ubiquitination | NSTVQQFKEAISKRF CHHHHHHHHHHHHHH | 41.73 | 22790023 | |
| 63 | Ubiquitination | QFKEAISKRFKSQTD HHHHHHHHHHHHHHH | 56.60 | 27667366 | |
| 66 | Ubiquitination | EAISKRFKSQTDQLV HHHHHHHHHHHHHEE | 45.76 | 22790023 | |
| 79 | Ubiquitination | LVLIFAGKILKDQDT EEEEEECHHHCCHHH | 41.24 | 22790023 | |
| 245 | Phosphorylation | NPDIMRQTLEIARNP CHHHHHHHHHHHHCH | 18.92 | 29899451 | |
| 267 | Phosphorylation | RNQDLALSNLESIPG HCCCHHHHCCCCCCC | 33.49 | 27600695 | |
| 271 | Phosphorylation | LALSNLESIPGGYNA HHHHCCCCCCCHHHH | 36.93 | 28066266 | |
| 276 | Phosphorylation | LESIPGGYNALRRMY CCCCCCHHHHHHHHH | 11.81 | 29514104 | |
| 283 | Phosphorylation | YNALRRMYTDIQEPM HHHHHHHHHHCHHHH | 10.23 | 25777480 | |
| 284 | Phosphorylation | NALRRMYTDIQEPML HHHHHHHHHCHHHHH | 19.79 | 25777480 | |
| 305 | Phosphorylation | FGGNPFATVGSSSTS HCCCCCCCCCCCCCC | 26.27 | 25777480 | |
| 308 | Phosphorylation | NPFATVGSSSTSGEG CCCCCCCCCCCCCCC | 19.44 | 25777480 | |
| 309 | Phosphorylation | PFATVGSSSTSGEGT CCCCCCCCCCCCCCC | 31.54 | 26239621 | |
| 310 | Phosphorylation | FATVGSSSTSGEGTQ CCCCCCCCCCCCCCC | 28.43 | 25777480 | |
| 311 | Phosphorylation | ATVGSSSTSGEGTQP CCCCCCCCCCCCCCC | 42.57 | 25777480 | |
| 312 | Phosphorylation | TVGSSSTSGEGTQPS CCCCCCCCCCCCCCC | 36.47 | 25777480 | |
| 316 | Phosphorylation | SSTSGEGTQPSRTEN CCCCCCCCCCCCCCC | 32.76 | 25777480 | |
| 319 | Phosphorylation | SGEGTQPSRTENRDP CCCCCCCCCCCCCCC | 41.85 | 25777480 | |
| 635 | Phosphorylation | AIERLLGSQPS---- HHHHHHCCCCC---- | 38.60 | 28066266 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBQL2_MOUSE !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBQL2_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBQL2_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ITB3_MOUSE | Itgb3 | physical | 10549293 | |
| CD47_MOUSE | Cd47 | physical | 10549293 | |
| HSP7C_MOUSE | Hspa8 | physical | 27477512 | |
| HSP72_MOUSE | Hspa2 | physical | 27477512 | |
| HS71L_MOUSE | Hspa1l | physical | 27477512 | |
| HS71B_MOUSE | Hspa1b | physical | 27477512 | |
| PRS6B_MOUSE | Psmc4 | physical | 27477512 | |
| PSMD3_MOUSE | Psmd3 | physical | 27477512 | |
| PRS8_MOUSE | Psmc5 | physical | 27477512 | |
| UBC_MOUSE | Ubc | physical | 27477512 | |
| UBQL1_MOUSE | Ubqln1 | physical | 27477512 | |
| UBQL4_MOUSE | Ubqln4 | physical | 27477512 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations."; Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.; Mol. Cell. Proteomics 6:283-293(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. | |
| "Phosphoproteomic analysis of the developing mouse brain."; Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.; Mol. Cell. Proteomics 3:1093-1101(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. | |